Drug Profile
Human rabies immunoglobulin vaccine - Bio Products Laboratory
Alternative Names: BPL HRIG; HRIGLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Bio Products Laboratory
- Class Antivirals; Vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II/III Rabies
Most Recent Events
- 30 Mar 2021 Human rabies immunoglobulin vaccine is still in phase-II/III clinical trials in Rabies (In volunteers, Prevention, Combination therapy) in USA (IM) (Bio Products Laboratory website, March 2021)
- 08 Dec 2017 Phase-II/III clinical trials in Rabies (In volunteers, Prevention, Combination therapy) in USA (IM) (NCT03264157)